Certified by Founder Lodge
TRexBio
United States - South San Francisco, California
START UP
1 Disclosed Funding Rounds $84,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
TRexBio is a discovery stage biotechnology company leveraging cutting edge computational biology tools, a focus on human tissue, and expertise in immunobiology to develop revolutionary therap
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 14 ,2024 | Series B | $84,000,000 | |
| January, 28 ,2026 | Unknown | $50,000,000.00 |
Johnson & Johnson
Polaris Partners
SV Health Investors
Pfizer
Agent Capital
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Manufact (formerly mcp-use) | $6,300,000 | (Feb 13, 2026)
CYDELPHI | $3,000,000 | (Feb 13, 2026)
Integrate | $17,000,000 | (Feb 13, 2026)
Maestro Tech, Inc. | $1,200,000 | (Feb 13, 2026)
Reflow | $15,000,000 | (Feb 13, 2026)
